Mohit Divakar
41 posts

Mohit Divakar
@mkdivakar
Genomic_Adventurer
New Delhi, India Katılım Ekim 2015
74 Takip Edilen53 Takipçiler

Beyond honoured and grateful to have received the prestigious Harold Gunson Fellowship for the year 2023! This recognition is definitely a motivation to explore deeper😇. Thanks to my mentor @vinodscaria for all the guidance throughout my #PhD journey!
@ISBTCO #isbtgothenburg

English
Mohit Divakar retweetledi

Comprehensive genome-scale map of structural variants in #India from whole #genome sequences. Congrats to the team led by @mkdivakar @IGIBSocial #IndiGen @vinodscaria
rdcu.be/c57Lg
Vinod Scaria@vinodscaria
It is a pleasure to share the new publication on the comprehensive genome-scale map of structural variants in #India from whole #genome sequences authored by @mkdivakar et al. from @SridharSivasub3 Lab at @IGIBSocial #IndiGen rdcu.be/c57Lg
English
Mohit Divakar retweetledi

It is a pleasure to share the new publication on the comprehensive genome-scale map of structural variants in #India from whole #genome sequences authored by @mkdivakar et al. from @SridharSivasub3 Lab at @IGIBSocial #IndiGen
rdcu.be/c57Lg

English
Mohit Divakar retweetledi

🆕Here is a First Report on Current #lumpyskindisease Outbreak, In India.
Genetic and Phylogenetic analysis of the LSD Viral Isolate from the Current LSD Outbreak in India Suggest a Distinct Lineage of the Virus.
@vinodscaria @bani_jolly @SridharSivasub3
👇biorxiv.org/content/10.110…

English
Mohit Divakar retweetledi

Join us as Dr @SridharSivasub3 from @IGIBSocial discusses relevance of genomic surveillance of #SARSCoV2 and adapting @illumina COVIDseq test for benchtop sequencers.
Register here: us02web.zoom.us/webinar/regist…

English
Mohit Divakar retweetledi

A protocol from @SridharSivasub3 lab on adapting the COVIDseq protocol for @illumina MiSeq benchtop sequencers
@RcBHOYAR @VickyMJ93 @bani_jolly @mohamedimran_s @mkdivakar @Abhinav_Jain_19
Access the protocol: osf.io/6e5cw/
@IGIBSocial @CSIR_IND #CSIRfightsCOVID19

English
Mohit Divakar retweetledi

A recent preprint from our lab is a modification of the @illumina COVIDSeq assay for SARS-CoV-2 genome sequencing, this assay could benefit from optimization for smaller throughput Illumina benchtop types of equipment for smaller batch sizes.
Available at: osf.io/6e5cw/

English
Mohit Divakar retweetledi

Recent preprint in collaboration with clinicians at Govt Medical College Kozhikode, Ernakulam and Idukki and @SridharSivasub3 lab at @IGIBSocial on genomic survey of #SARSCoV2 vaccine breakthrough infections from #Kerala #India
Read the preprint here osf.io/85ndu/

English
Mohit Divakar retweetledi
Mohit Divakar retweetledi
Mohit Divakar retweetledi

Publication out from @vinodscaria @SridharSivasub3 and CSIR group in India using Illumina COVIDSeq to sequence 200 samples from patients in Kerala region of India. They were able to identify new variants and uncover unique patterns of transmission.
#SM7" target="_blank" rel="nofollow noopener">frontiersin.org/articles/10.33…
English
Mohit Divakar retweetledi

I'm going to disagree. Things don't just work because scientists work hard and show up every day. There is a huge component of luck and timing of convergence of multiple technologies at just the right time. The hard work is necessary but so is the timing/luck (miracle).
Tanentzapf Lab@TanentzapfLab
Joe Biden keeps saying that the vaccine is a "miracle of science". But there's no "miracle" to science, just many thousands of scientists showing up to work day in day out, taking little baby steps, failing again & again but keeping at it, bravely tackling the mysteries of nature
English
Mohit Divakar retweetledi

A short video overview on #SARSCoV2 Genome Sequencing at @CSIR_IND @IGIBSocial
youtu.be/svNn84dYts4
#CSIRfightsCOVID19 Credits: @VickyMJ93

YouTube

English
Mohit Divakar retweetledi

For the 1st time, Officially Reviewed 2 research articles.
1st paper got summarily rejected in initial review, potentially due to unrealistic claims with limited data and overlooking other observations.
2nd paper is finally accepted with 2 revisions in 3 months.
#Reviewer
English
Mohit Divakar retweetledi

Publication on the evaluation of the high-throughput multiplex amplicon based sequencing approach (#COVIDseq) for genomic surveillance of #SARSCoV2
#MegaLab @SridharSivasub3
Read more at journals.plos.org/plosone/articl…
#CSIRfightsCOVID19 @CSIR_IND @IGIBSocial
@illumina

English
Mohit Divakar retweetledi

Website on the Genetic Epidemiology of SARS-CoV-2 in #Kerala is now online at genescov2.genomes.in
@KeralaHealth @Arogyakeralam @CSIR_IND @IGIBSocial
#CSIRfightsCOVID19 #GENESCOV2

English
Mohit Divakar retweetledi

Could anyone please help us by pointing out literature / patent / preprints describing the sequences/structure of spike / inactivated virus(es) used in the #SARSCoV2 vaccines approved / under trials / under development ?
Please 🔁 with anyone who could help.

English



